Cell membrane glycoproteins and Langerhans cells.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000276:immunology; D000954:Antigens, Surface / Q000032:analysis*; D002455:Cell Division; D002462:Cell Membrane / Q000276:immunology / Q000648:ultrastructure; D002465:Cell Movement; D006023:Glycoproteins / Q000032:analysis*; D006680:HLA Antigens / Q000032:analysis; D006684:HLA-DR Antigens; D006646:Histiocytosis, Langerhans-Cell / Q000276:immunology / Q000473:pathology; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D006965:Hyperplasia; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007801:Langerhans Cells / Q000276:immunology* / Q000473:pathology / Q000648:ultrastructure; D008221:Lymphoid Tissue / Q000166:cytology; D008285:Major Histocompatibility Complex; D008565:Membrane Proteins / Q000032:analysis*; D008970:Molecular Weight; D012867:Skin / Q000276:immunology; D012871:Skin Diseases / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D001613:beta 2-Microglobulin / Q000032:analysis
D000906:Antibodies; D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D006023:Glycoproteins; D006680:HLA Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D008565:Membrane Proteins; D001613:beta 2-Microglobulin